Lecture 7: Clinical Development Pathways
Nucleate Seattle is excited to announce we are hosting a panel on Clinical Development Pathways for biotech companies. Come gain insight into how biotech companies prepare for clinical validation and learn more about the FDA/health regulations that are required before bringing innovations to market!
Come hear from Eva Yin (Wilson Sonsini) and Arna Stoll (Wavely Diagnostics) about how to navigate these regulatory processes and how to incorporate these during the development of your product!
This event will provide practical advice on transitioning from academia to bio-entrepreneurship, and provide critical insight into how biotech companies prepare for clinical validation! Don’t miss this opportunity to learn from and network with industry leaders!
Location: UW CoMotion - Fluke Hall
Format: 1-hour long moderated panel discussion, followed by audience Q&A and short networking Happy Hour
We kindly ask all registered attendees to arrive at least 10 mins prior to the start of the event. If you have any questions, please contact Nucleate Seattle.
Nucleate is a global student-run nonprofit organization that facilitates the formation of new life science ventures. Our mission is to empower the next-generation of biotech leaders through open-access biotech programming. Our flagship Activator program supports scientific trainees who plan to tackle the biggest challenges in human health by building life science startups.